scholarly journals Osimertinib in advanced or metastatic non-small cell lung cancer patients with EGFR T790M mutation after treatment with EGFR-TKI: Interim analysis of China cohort from the single-arm, open-label, international, multi-center real-world ASTRIS study

2018 ◽  
Vol 29 ◽  
pp. ix158
Author(s):  
Q. Zhou ◽  
H. Zhang ◽  
L. Jiang ◽  
Y. Shi ◽  
Y. Chen ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document